Awarded contractOpenSuppliesGermany
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Bimekizumab, ATC L04AC21 für die Zeit 01.10.2024 - 30.09.2026
1 lot awarded•€1 awarded
Buyer: DAK-Gesundheit / Hamburg, Germany
Published Sep 30, 2026Awarded Sep 30, 2024
Pharmaceutical products
Awarded value
€1.0
Estimated value
€1.0
Awarded at 100% of estimated value
Award date
Sep 30, 2024
Winners
0
Lots awarded
1
Winners
No winners specified.
Lots awarded
| Lot | Title | Winner | Award value | Main CPV |
|---|---|---|---|---|
| LOT-0001 | Not specified | — | Pharmaceutical products (33600000) |